NeuroOne Medical Technologies Corporation
NMTC
$0.823
$0.0658.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -57.65% | 1,102.42% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -57.65% | 1,102.42% | |||
| Cost of Revenue | -73.40% | 102.40% | |||
| Gross Profit | -5.06% | 177.60% | |||
| SG&A Expenses | -5.05% | 10.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 160.18% | -49.40% | |||
| Operating Income | -256.62% | 160.75% | |||
| Income Before Tax | -227.18% | 153.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -227.18% | 153.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -227.18% | 153.28% | |||
| EBIT | -256.62% | 160.75% | |||
| EBITDA | -247.18% | 164.53% | |||
| EPS Basic | -226.08% | 151.51% | |||
| Normalized Basic EPS | -247.79% | 151.57% | |||
| EPS Diluted | -226.08% | 151.51% | |||
| Normalized Diluted EPS | -248.20% | 151.42% | |||
| Average Basic Shares Outstanding | 0.89% | 3.45% | |||
| Average Diluted Shares Outstanding | 0.75% | 3.59% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||